- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03437122
Project A3sc - An Atlas of Airways at a Single Cell Level (AAAsc)
The increasing incidence of chronic respiratory diseases is a public health problem affecting hundreds of thousands of people around the world, including children. Directly exposed to atmospheric aerocontaminants (pollution, allergens), the respiratory tracts represent a complex ecosystem that involves different cells that develop complex interactions with the surrounding connective tissue but also with their rich immune environment and with the microbiota. Although a pathophysiological continuum is postulated between the nasal and bronchial airways in certain diseases, such as allergic diseases, we have identified broad gradients in gene expression between nasal and bronchial samples. This is why cellular variability throughout the respiratory tree needs to be studied in detail.
The sequencing of RNAs specifically present in a particular cell, and its comparison with neighboring cells, allows us to document precise cellular contributions and intercellular relationships. Our project will establish protocols to stabilize airway swabs by brushing and/or biopsy, under conditions that will then allow the analysis of gene expression profiles at the single cell level (single cell RNA sequencing).
The development of the "single cell" stabilisation and analysis protocol will first be carried out on primary respiratory epithelium cultures and then extended to respiratory specimens taken from healthy volunteers. Through sampling at several levels of the respiratory tree, variations in expression along the tracheobronchial axis will be fully documented. Finally, the interaction between the epithelial compartment and the immunological compartment will be studied by analyzing gene expression on a single cell in different physiopathological contexts.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nice, France, 06003
- CHU de Nice
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age ≥ 18 years and <40 years
- non-smoker
- absence of known acute or chronic disease
- absence of symptoms suggestive of progressive disease
- normal clinical examination
Exclusion Criteria:
- recent rhino-bronchial infection (<6 weeks)
- mental disability
- pregnant women (a urine test will be performed for all women of childbearing age)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: All
|
Multiple level sampling of the respiratory mucosa (cytology brush and biopsies forceps)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of samples usable
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 17-PP-14
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory System
-
VA Office of Research and DevelopmentCompletedAutonomic Nervous System | Abnormality, Respiratory SystemUnited States
-
PulmOne Advanced Medical Devices, Ltd.CompletedTLC in Patients With and Without Respiratory System DiseaseIsrael
-
EMSCompletedFlu | Cold | Allergic Disorder of Respiratory System
-
Centre Hospitalier Universitaire de NiceCompleted
-
University Hospital, RouenCompletedPulmonary Nodule Persistent | Malignant Neoplasm of the Respiratory System | Benign Neoplasms of the Respiratory SystemFrance
-
Wolfson Medical CenterCompletedThe Nature of Reflux-respiratory Symptoms Association in Difficult to Treat Wheezing\Coughing BabiesCough | Asthma | WheezingIsrael
-
Centre d'Investigation Clinique et Technologique...Adep AssistanceTerminatedRespiratory FailureFrance
-
Southeast University, ChinaCompleted
-
University Hospital, BordeauxCompletedRespiratory Failure | Acute Respiratory InsufficiencyFrance
-
University of VersaillesAdep AssistanceCompletedChronic Respiratory FailureFrance
Clinical Trials on Bronchoscopy
-
Ankara Ataturk Sanatorium Training and Research...Yenimahalle Education and Research HospitalCompletedIntensive Care Unit | Tracheal StenosisTurkey
-
Tang-Du HospitalChanghai Hospital; The First Affiliated Hospital of Guangzhou Medical University and other collaboratorsTerminated
-
Jiayuan SunUnknown
-
Wake Forest University Health SciencesOhio State University; University of Mississippi Medical CenterCompletedBone Marrow TransplantationUnited States
-
Charite University, Berlin, GermanyUniversity of Luebeck; NeuroCure Clinical Research Center, Charite, Berlin; University... and other collaboratorsRecruiting
-
Centre Hospitalier Universitaire de NiceCompleted
-
University of VirginiaCompleted
-
University Medical Center GroningenUnknownAsthma | Allergic AsthmaNetherlands
-
Fundació Institut de Recerca de l'Hospital de la...Sociedad Española de Neumología y Cirugía Torácica; Instituto de Salud Carlos...UnknownBacterial Infection in COPDSpain